Abstract
Purpose
To evaluate the performances of five different βhCG follow-up protocols after single-dose methotrexate therapy for tubal ectopic pregnancy (EP).
Methods
Data of patients who received single-dose methotrexate therapy for tubal EP at a university hospital between January 2011 and July 2016 were reviewed. A ‘successful methotrexate treatment’ was defined if the EP treated with no need for surgery. The performances of different protocols were tested by comparing with the currently used ‘15% βhCG decrease between days 4 and 7’ protocol. The tested follow-up protocols were ‘20, 25%, and any βhCG decrease between days 0/1 and 7’ and ‘20% and any βhCG decrease between days 0/1 and 4’.
Results
Among the 96 patients evaluated, 12 (12.5%) required second dose. Totally, 91 (94.8%) patients treated successfully with no need for surgery. Four patients were operated within 4 days following the second dose. One patient who did not need second dose according to the standard follow-up protocol was operated on the 10th day due to rupture (specificity = 80%). Two protocols, namely ‘20% βhCG decrease between days 0/1 and 7’ and ‘any βhCG decrease between days 0/1 and 7’ did not show statistically significant differences from the index protocol regarding the number of patients who should be assigned to 2nd dose.
Conclusions
‘Any βhCG decrease between days 0/1 and 7’ protocol may substitute the currently used one to decide second dose methotrexate in tubal EP management. Omitting 4th day measurement seems to be more convenient and cost effective.
Similar content being viewed by others
References
Hajenius PJ, Mol F, Mol BW et al (2007) Interventions for tubal ectopic pregnancy. Cochrane Database Syst Rev. doi:10.1002/14651858.CD000324.pub2
Chang J, Elam-Evans LD, Berg CJ et al (2003) Pregnancy-related mortality surveillance—United States, 1991–1999. MMWR Surveill Summ 52:1–8
Berg CJ, Callaghan WM, Henderson Z et al (2010) Pregnancy-related mortality in the United States, 1998 to 2005. Obstet Gynecol 116:1302–1309
Tanaka T, Hayashi H, Kutsuzawa T et al (1982) Treatment of interstitial ectopic pregnancy with methotrexate: report of a successful case. Fertil Steril 37:851–852
Stovall TG, Ling FW, Gray LA (1991) Single-dose methotrexate for treatment of ectopic pregnancy. Obstet Gynecol 77:754–757
Kirk E, Condous G, Van Calster B et al (2007) A validation of the most commonly used protocol to predict the success of single-dose methotrexate in the treatment of ectopic pregnancy. Hum Reprod 22:858–863
Oron G, Tulandi T (2013) A pragmatic and evidence-based management of ectopic pregnancy. J Minim Invasive Gynecol 120:446–454
Nguyen Q, Kapitz M, Downes K et al (2010) Are early human chorionic gonadotropin levels after methotrexate therapy a predictor of response in ectopic pregnancy? Am J Obstet Gynecol 202:630.e1–630.e5
Skubisz M, Dutton P, Duncan WC et al (2010) Using a decline in serum hCG between days 0–4 to predict ectopic pregnancy treatment success after single-dose methotrexate: a retrospective cohort study. BMC Pregnancy Childbirth 13:30
Atkinson M, Gupta S, McGee T (2014) βhCG monitoring after single-dose methotrexate treatment of tubal ectopic pregnancy: is the Day 4 βhCG necessary? A retrospective cohort study. Aust N Z J Obstet Gynaecol 54:475–479
Yildirim A, Akdag Cirik D, Altay M et al (2015) Early prediction for the requirement of second or third dose methotrexate in women with ectopic pregnancy, treated with single-dose regimen. Arch Gynecol Obstet 291:1327–1332
Author information
Authors and Affiliations
Contributions
YES: Data management, Manuscript writing/editing. KK: Data collection, manuscript writing. MMS: Interpretation. EC: Interpretation. FD: Protocol/project development, Interpretation, Management.
Corresponding author
Ethics declarations
Conflict of interest statement
The authors of this article report no conflict of interest.
Ethical approval
All procedures performed were in accordance with the ethical standards of the institutional review board and with the Helsinki Declaration or comparable ethical standards.
Rights and permissions
About this article
Cite this article
Şükür, Y.E., Koyuncu, K., Seval, M.M. et al. Comparison of alternative βhCG follow-up protocols after single-dose methotrexate therapy for tubal ectopic pregnancy. Arch Gynecol Obstet 296, 1161–1165 (2017). https://doi.org/10.1007/s00404-017-4527-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-017-4527-1